Inhibrx Biosciences, Inc. (INBX)
NASDAQ·Healthcare·Biotechnology
$96.20
+3.32%
Mkt Cap $1.31B
No analyst coverage available
We don't have analyst ratings or price target data for Inhibrx Biosciences, Inc. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.